MicroRNAs in prostate cancer

MicroRNAs (miRNAs) are made up of -22 endogenous nucleotides and are small, noncoding RNAs that are important regulators of gene expression at the posttranscriptional level by degrading or repressing target miRNAs. miRNA expression profiles can be used for the detection of diagnostic and prognostic...

Full description

Bibliographic Details
Main Authors: Won Tae Kim, Wun-Jae Kim
Format: Article
Language:English
Published: Elsevier 2013-03-01
Series:Prostate International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888215300088
_version_ 1797722942456463360
author Won Tae Kim
Wun-Jae Kim
author_facet Won Tae Kim
Wun-Jae Kim
author_sort Won Tae Kim
collection DOAJ
description MicroRNAs (miRNAs) are made up of -22 endogenous nucleotides and are small, noncoding RNAs that are important regulators of gene expression at the posttranscriptional level by degrading or repressing target miRNAs. miRNA expression profiles can be used for the detection of diagnostic and prognostic markers for various cancers. Also, alterations of miRNAs in cancer tissues have been associated with clinicopathological parameters. Along with circulating miRNAs, tissue miRNAs have shown promise as markers that can predict cancer recurrence and/or the potential for survival of cancer patients. Additionally, some miRNAs have therapeutic potential. In this review, we discuss and assess the usefulness of tissue-derived and circulating miRNAs for the diagnosis and prognosis of prostate cancer.
first_indexed 2024-03-12T09:55:02Z
format Article
id doaj.art-fb019b510aa84f9a82050393856fa64d
institution Directory Open Access Journal
issn 2287-8882
language English
last_indexed 2024-03-12T09:55:02Z
publishDate 2013-03-01
publisher Elsevier
record_format Article
series Prostate International
spelling doaj.art-fb019b510aa84f9a82050393856fa64d2023-09-02T12:18:05ZengElsevierProstate International2287-88822013-03-01113910.12954/PI.12011MicroRNAs in prostate cancerWon Tae KimWun-Jae KimMicroRNAs (miRNAs) are made up of -22 endogenous nucleotides and are small, noncoding RNAs that are important regulators of gene expression at the posttranscriptional level by degrading or repressing target miRNAs. miRNA expression profiles can be used for the detection of diagnostic and prognostic markers for various cancers. Also, alterations of miRNAs in cancer tissues have been associated with clinicopathological parameters. Along with circulating miRNAs, tissue miRNAs have shown promise as markers that can predict cancer recurrence and/or the potential for survival of cancer patients. Additionally, some miRNAs have therapeutic potential. In this review, we discuss and assess the usefulness of tissue-derived and circulating miRNAs for the diagnosis and prognosis of prostate cancer.http://www.sciencedirect.com/science/article/pii/S2287888215300088Prostatic neoplasmsMicroRNAsBiological markers
spellingShingle Won Tae Kim
Wun-Jae Kim
MicroRNAs in prostate cancer
Prostate International
Prostatic neoplasms
MicroRNAs
Biological markers
title MicroRNAs in prostate cancer
title_full MicroRNAs in prostate cancer
title_fullStr MicroRNAs in prostate cancer
title_full_unstemmed MicroRNAs in prostate cancer
title_short MicroRNAs in prostate cancer
title_sort micrornas in prostate cancer
topic Prostatic neoplasms
MicroRNAs
Biological markers
url http://www.sciencedirect.com/science/article/pii/S2287888215300088
work_keys_str_mv AT wontaekim micrornasinprostatecancer
AT wunjaekim micrornasinprostatecancer